TY - JOUR
T1 - Antigenic variation in visna virus
AU - Scott, Jane V.
AU - Stowring, Linda
AU - Haase, Ashley T.
AU - Narayan, Opendra
AU - Vigne, Robert
N1 - Funding Information:
This project was supported by grants from the American Cancer Society, the USPHS and the Hamilton Roddis Foundation. R. V. was supported by the International Agency for Research on Cancer. A. T. H. is a medical investigator of the Veterans Administration. We thank Harriett Lukes for typing the manuscript. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
PY - 1979/10
Y1 - 1979/10
N2 - Two antigenic variants of visna virus were isolated sequentially from a single sheep inoculated with a plaque-purified strain of virus designated 1514. The genetically stable variants, LV1-1 and LV1-4, are of two classes: LV1-1 is partially neutralized by antibody to the inoculum strain 1514, while LV1-4 is not neutralized by antibody to 1514. The genetic mechanism responsible for generating the antigenic variants was investigated by comparing the chymotryptic and tryptic maps of the envelope glycoprotein gp135 and core polypeptides (p30, p16, p14), and by comparing the pattern of large oligonucleotides produced by digestion of the RNAs by T1 ribonuclease. We show that only the peptide maps of gp135 differ among strains, that the number of peptide fragments altered is small and that gp135 is the polypeptide that elicits neutralizing antibody. The maps of the RNAs are identical. We conclude that mutation in the glycoprotein gene rather than recombination is more probably responsible for antigenic variation, and speculate on the special aspects of visna virus replication relevant to this phenomenon.
AB - Two antigenic variants of visna virus were isolated sequentially from a single sheep inoculated with a plaque-purified strain of virus designated 1514. The genetically stable variants, LV1-1 and LV1-4, are of two classes: LV1-1 is partially neutralized by antibody to the inoculum strain 1514, while LV1-4 is not neutralized by antibody to 1514. The genetic mechanism responsible for generating the antigenic variants was investigated by comparing the chymotryptic and tryptic maps of the envelope glycoprotein gp135 and core polypeptides (p30, p16, p14), and by comparing the pattern of large oligonucleotides produced by digestion of the RNAs by T1 ribonuclease. We show that only the peptide maps of gp135 differ among strains, that the number of peptide fragments altered is small and that gp135 is the polypeptide that elicits neutralizing antibody. The maps of the RNAs are identical. We conclude that mutation in the glycoprotein gene rather than recombination is more probably responsible for antigenic variation, and speculate on the special aspects of visna virus replication relevant to this phenomenon.
UR - http://www.scopus.com/inward/record.url?scp=0018662457&partnerID=8YFLogxK
U2 - 10.1016/0092-8674(79)90051-5
DO - 10.1016/0092-8674(79)90051-5
M3 - Article
C2 - 227603
AN - SCOPUS:0018662457
SN - 0092-8674
VL - 18
SP - 321
EP - 327
JO - Cell
JF - Cell
IS - 2
ER -